135
Participants
Start Date
June 3, 2024
Primary Completion Date
August 31, 2027
Study Completion Date
November 30, 2027
Prolonged exposure therapy
Twelve weekly 60-minute telemedicine-delivered prolonged exposure therapy sessions provided by therapists trained in prolonged exposure therapy.
Financial incentives
Financial incentives contingent upon completion of prolonged exposure therapy sessions
Treatment as usual
Continued standard buprenorphine or methadone maintenance treatment from current treatment provider.
RECRUITING
University of Vemont, Burlington
National Institute on Drug Abuse (NIDA)
NIH
University of Vermont
OTHER